Back to search
Multi-Drug Resistant Organism Colonization
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Multi-Drug Resistant Organism Colonization trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Multi-Drug Resistant Organism Colonization trials you may qualify forThe purpose of this study is to better understand the effectiveness and safety of microbiome therapies (MT) as a treatment for patients with Multidrug Resistant…
REACT is a phase two, open-label, randomized, controlled trial of microbiota therapy (MT) to reduce colonization with multi-drug resistant organisms (MDRO). REA…
The goal of this clinical trial is to test whether lyophilized fecal microbime transfer - a dried extract of bacteria from the stool of healthy donors - is bett…
This proposed protocol involves the use of the fecal microbiota transplantation (FMT) to suppress or reverse colonization with multidrug resistant organisms (MD…